Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-24 @ 11:52 AM
NCT ID:
NCT05140161
Eligibility Criteria:
Inclusion Criteria:
* STADIUM I, II, or III (Kline classification) without infective onychocryptosis (cellulitis) on both edges of the Hallux
* Susceptible to phenol-alcohol technique with Suppan I modification
Exclusion Criteria:
* Platelet Antiplatelet Therapy
* Oral Anticoagulant Therapy
* History of congenital or acquired Hemorrhagic Syndrome
* Alteration in the following parameters (platelet count, prothrombin time, activated thromboplastin time, and plasma fibrinogen)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
70 Years
Study:
NCT05140161
Study Brief:
Protocol Section:
NCT05140161